Allscripts (MDRX) Misses Q3 EPS by 1c; Guides Q4 EPS Below Views

November 3, 2016 4:29 PM EDT
Get Alerts MDRX Hot Sheet
Trade MDRX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $392 million versus the consensus estimate of $414.92 million.

GUIDANCE:

Allscripts sees Q4 2016 EPS of $0.14-$0.16, versus the consensus of $0.17. Allscripts sees Q4 2016 revenue of $420-435 million, versus the consensus of $425.4 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings

Add Your Comment